✦ LIBER ✦

A phase I pharmacokinetic study of the vascular disrupting agent ombrabulin (AVE8062) and docetaxel in advanced solid tumours

✍ Scribed by Eskens, F A L M; Tresca, P; Tosi, D; Van Doorn, L; Fontaine, H; Van der Gaast, A; Veyrat-Follet, C; Oprea, C; Hospitel, M; Dieras, V

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I clinical and pharmacokinetic stu

✍ Bahleda, Rastislav; Sessa, Cristiana; Del Conte, Gianluca; Gianni, Luca; Capri, 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 846 KB

386 Phase I study of the vascular disrup

✍ J.C. Soria; R. Bahleda; B. Besse; C. Sessa; R.g. Calderone; L. Gianni; G. Del Co 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 64 KB

Phase I safety and pharmacokinetic study

✍ M.J.A. de Jonge; H. Dumez; J.J.E.M. Kitzen; B. Beuselinck; J. Verweij; R. Courtn 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 305 KB

A phase I and pharmacokinetic study of t

✍ Samir D. Undevia; Federico Innocenti; Jacqueline Ramirez; Larry House; Apurva A. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 191 KB

Cabazitaxel in patients with advanced so

✍ V. Diéras; A. Lortholary; V. Laurence; R. Delva; V. Girre; A. Livartowski; S. As 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 396 KB

Phase 1 study of the novel vascular disr

✍ Michael Millward, Paul Mainwaring, Alain Mita, Kristine Federico, G. K. Lloyd, N 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 274 KB